These results, along with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the strategy of focusing on ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Diseases. These effects counsel that https://franzv922bxu3.blog4youth.com/profile